Business & Finance
Iomai announces second quarter $7.5 million loss, reports on business progress
Published in TB and Outbreaks Week, September 12th, 2006
Iomai Corp. (IOMI) reported financial results and corporate progress for the second quarter ended June 30, 2006 with a net loss available to common stockholders of $7.5 million, representing a $0.45 loss per share (based on a weighted average number of shares outstanding of 16,908,231), compared to a net loss available to common stockholders in the second quarter of 2005 of $5.1 million, or $6.57 loss per share (based on a weighted average number of shares outstanding of 773,523).
The lower net loss per share in the second quarter of 2006 was attributable to the increase in the weighted average number of shares outstanding due to the company's initial public offering in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Influenza Virus
H5N1 influenza virus evolving and adapting in avian and human hosts - Malaria Transmission
Malaria transmission rate low in Dakar but increased gene polymorphisms increase disease severity - Methicillin-Resistant Staphylococcus Aureus Outbre
Community-acquired methicillin-resistant Staphylococcus aureus outbreak occurred among high-risk population in Canada - Travel Medicine
Classic infectious mononucleosis-like syndrome features often lacking in febrile travelers - Tuberculosis Epidemiology
Tuberculosis skin testing conversion rates determined for U.S. Navy and Marine Corps - Antifungal Therapy
Nasal antifungal therapy does not influence cell activation markers in chronic rhinosinusitis - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
